ReviewComputational and structural biotechnology journal2021
Sustainable metabolic engineering for sustainability optimisation of industrial biotechnology.
Review in Computational and structural biotechnology journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Yarrowia lipolytica and Komagataella phaffii (Pichia pastoris) as Hosts for Heterologous Expression of Lipases.Methods in molecular biology (Clifton, N.J.) · 2027Article
- Epigenome Engineering Using dCas Systems for Biomedical Applications and Biotechnology: Current Achievements, Opportunities and Challenges.International journal of molecular sciences · 2025Review
- A Fermentation State Marker Rule Design Task in Metabolic Engineering.Bioengineering (Basel, Switzerland) · 2023Article
- Peptide extract from spent yeast improves resistance of Saccharomyces cerevisiae to oxidative stress.Applied microbiology and biotechnology · 2023Article
- OptEnvelope: A target point guided method for growth-coupled production using knockouts.PloS one · 2023Article
- Kinetic and Stoichiometric Modeling-Based Analysis of Docosahexaenoic Acid (DHA) Production Potential byMarine drugs · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Industrial biotechnology represents one of the most innovating and labour-productive industries with an estimated stable economic growth, thus giving space for improvement of the existing and setting up new value chains. In addition, biotechnology has clear environmental advantages over the chemical industry. Still, biotechnology's environmental contribution is sometimes valued with controversy and societal aspects are frequently ignored. Environmental, economic and societal sustainability of various bioprocesses becomes increasingly important due to the growing understanding about complex and interlinked consequences of different human activities. Neglecting the sustainability issues in the development process of novel solutions may lead to sub-optimal biotechnological production, causing adverse environmental and societal problems proportional to the production volumes. In the paper, sustainable metabolic engineering (SME) concept is proposed to assess and optimize the sustainability of biotechnological production that can be derived from the features of metabolism of the exploited organism. The SME concept is optimization of metabolism where economic, environmental and societal sustainability parameters of all incoming and outgoing fluxes and produced biomass of the applied organisms are considered. The extension of characterising features of strains designed by metabolic engineering methods with sustainability estimation enables
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.